Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas

被引：0
|
作者：
Van Tine, Brian Andrew
Chen, Christopher T.
Moreno, Victor
Davis, Elizabeth J.
de Miguel, Maria J.
Italiano, Antoine
Saada-Bouzid, Esma
Milhem, Mohammed
Valverde, Claudia
Chawla, Sant P.
Naqash, Abdul Rafeh
Carter, Louise
Jones, Robin
Conti, Ilaria
Boni, Joe
Havenith, Karin
LeBruchec, Yvan
Pantano, Serafino
Blay, Jean-Yves
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT059
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma
    Chawla, Sant P.
    Goel, Sanjay
    Chow, Warren
    Braiteh, Fadi
    Singh, Arun S.
    Olson, Juneko E. Grilley
    Osada, Atsushi
    Bobe, Iulian
    Riedel, Richard F.
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4225 - 4232
  • [2] Pharmacokinetics of trabectedin and olaparib given in combination during a phase 1b trial (NCT 02398058) in patients with advanced and non-resectable bone and soft tissue sarcomas
    Matteo, C.
    Zucchetti, M.
    D'Ambrosio, L.
    Pignochino, Y.
    Dovrtelova, G.
    Tolomeo, F.
    Merlini, A.
    Picci, P.
    Palmerini, E.
    D'incalci, M.
    Grignani, G.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E58 - E58
  • [3] Phase II trial of cetuximab in patients (pts) with metastatic and/or locally advanced soft tissue and bone sarcomas
    Ha, H. T.
    Chugh, R.
    Griffith, K. A.
    Thomas, D. G.
    Schuetze, S. M.
    Lucas, D. R.
    Biermann, J. S.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian Sarcoma Group (ISG) study.
    Grignani, Giovanni
    D'Ambrosio, Lorenzo
    Pignochino, Ymera
    Palmerini, Emanuela
    Zucchetti, Massimo
    Boccone, Paola
    Aliberti, Sandra
    Piana, Raimondo
    Palesandro, Erica
    Miano, Sara
    Stacchiotti, Silvia
    Tos, Angelo Paolo Dei
    Marchesi, Emanuela
    Bertulli, Rossella
    D'Incalci, Maurizio
    Picci, Piero
    Ferrari, Stefano
    Aglietta, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
    Hartmann, JT
    Oechsle, K
    Mayer, F
    Kanz, L
    Bokemeyer, C
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1899 - 1901
  • [6] Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
    Späth-Schwalbe, E
    Genvresse, I
    Koschuth, A
    Dietzmann, A
    Grunewald, R
    Possinger, K
    ANTI-CANCER DRUGS, 2000, 11 (05) : 325 - 329
  • [7] A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS)
    Lewin, Jeremy
    Malone, Eoghan
    Al-Ezzi, Esmail
    Fasih, Samir
    Pedersen, Pernille
    Accardi, Sarah
    Gupta, Abha
    Razak, Albiruni Abdul
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 360 - 367
  • [8] A phase 1b dose escalation trial of gemcitabine and nab-paclitaxel in combination with lixumistat in patients with advanced pancreatic cancer.
    Pant, Shubham
    Smaglo, Brandon George
    Huey, Ryan W.
    Haldar, Saurav Daniel
    Morelli, Maria Pia
    Willis, Jason
    Xiao, Lianchun
    Yuan, Ying
    Attanasio, Sergio
    Shah, Rutvi
    Citron, Francesca
    Zhao, Dan
    Kopetz, Scott
    Maitra, Anirban
    Welsch, Dean
    Sheth, Rahul
    Bhosale, Priya
    Wolff, Robert A.
    Viale, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 743 - 743
  • [9] Results from a dose escalation phase 1b study of palbociclib and avelumab in advanced breast cancer in the PAveMenT Trial
    Okines, Alicia F.
    Moghadam, Houman
    Sparks, Laura
    Mohammed, Kabir
    Dunne, Kathryn
    Nerurkar, Ashutosh
    Osin, Peter
    Swift, Claire
    Sardinha, Ruth
    Turner, Nicholas
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Pegylated liposomal doxorubicin combined with ifosfamide for advanced soft tissue sarcomas: A phase I dose-escalation study
    Ye, Ting
    Fan, Li
    Cao, Rubo
    Peng, Ling
    Chen, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345